BCI
PCVX icon

Brinker Capital Investments’s Vaxcyte PCVX Stock Holding History

Brinker Capital Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,861
Closed -$355K – 2167
2025
Q3 		$355K Buy
9,861
+52
+0.5% +$1.72K ﹤0.01% 1690
2025
Q2 		$319K Sell
9,809
-3,096
-24% -$101K ﹤0.01% 1678
2025
Q1 		$487K Buy
+12,905
New +$1.03M ﹤0.01% 1436
2024
Q4 		– Sell
-2,590
Closed -$296K – 1887
2024
Q3 		$296K Sell
2,590
-1,991
-43% -$179K ﹤0.01% 1526
2024
Q2 		$346K Sell
4,581
-267
-6% -$18.2K ﹤0.01% 1412
2024
Q1 		$331K Sell
4,848
-2,457
-34% -$170K ﹤0.01% 1420
2023
Q4 		$443K Buy
7,305
+1,050
+17% +$54.5K 0.01% 1261
2023
Q3 		$319K Buy
+6,255
New +$309K ﹤0.01% 1351

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return